4.2 Article

Spatial memory recovery in Alzheimer's rat model by electromagnetic field exposure

Journal

INTERNATIONAL JOURNAL OF NEUROSCIENCE
Volume 128, Issue 8, Pages 691-696

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/00207454.2017.1411353

Keywords

Alzheimer's disease; learning and memory; extremely-low-frequency electromagnetic fields (ELF-EMFs)

Categories

Funding

  1. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran [9324]

Ask authors/readers for more resources

Introduction: Although studies have shown a potential association between extremely low frequency electromagnetic fields (ELF-EMFs) exposure and Alzheimer's disease (AD), few studies have been conducted to investigate the effects of weak magnetic fields on brain functions such as cognitive functions in animal models. Therefore, this study aimed to investigate the effect of ELF-EMF exposure (50 Hz, 10 mT) on spatial learning and memory changes in AD rats.Methods: Amyloid- (A) 1-42 was injected into lateral ventricle to establish an AD rat model. The rats were divided into six groups: Group I (control); Group II (surgical sham); Group III (AD) Alzheimer's rat model; Group IV (MF) rats exposed to ELF-MF for 14 consecutive days; Group V (A injection+M) rats exposed to magnetic field for 14 consecutive days from day 0 to 14 days after the A peptide injection; Group VI (AD+M) rats exposed to magnetic field for 14 consecutive days after 2 weeks of A peptide injection from 14th to 28th day . Morris water maze investigations were performed.Results: AD rats showed a significant impairment in learning and memory compared to control rats. The results showed that ELF-MF improved the learning and memory impairments in A injection+M and AD+M groups.Conclusion: Our results showed that application of ELF-MF not only has improving effect on different cognitive disorder signs of AD animals, but also disrupts the processes of AD rat model formation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Otorhinolaryngology

Improving Swallowing Function and Ability in Post Stroke Dysphagia: A Randomized Clinical Trial

Sima Farpour, Majid Asadi-Shekaari, Afshin Borhani Haghighi, Hamid Reza Farpour

Summary: This study aimed to investigate the effectiveness of stimulating the supramarginal gyrus (SMG) in improving post-stroke dysphagia. The results showed that the real group, which received anodal stimulation on the intact SMG, had significantly higher improvements in swallowing function compared to the sham group. After one-month follow-up, most of the patients in the real group reached a higher level of swallowing ability.

DYSPHAGIA (2023)

Correction Nutrition & Dietetics

The combination of endurance exercise and SGTC (Salvia-Ginseng-Trigonella-Cinnamon) ameliorate mitochondrial markers' overexpression with sufficient ATP production in the skeletal muscle of mice fed AGEs-rich high-fat diet (vol 19, 17, 2022)

Maryam Haghparast Azad, Iman Niktab, Shaghayegh Dastjerdi, Navid Abedpoor, Golbarg Rahimi, Zahra Safaeinejad, Maryam Peymani, Farzad Seyed Forootan, Majid Asadi-Shekaari, Mohammad Hossein Nasr Esfahani, Kamran Ghaedi

NUTRITION & METABOLISM (2022)

Article Neurosciences

Modulation of the CB1 cannabinoid receptor has potential therapeutic utility in the 3-acetylpyridine cerebellar ataxia rat model

Hoda Ranjbar, Monavareh Soti, Mahyar Janahmadi, Kristi A. Kohlmeier, Vahid Sheibani, Meysam Ahmadi-Zeidabadi, Mohammad Shabani

Summary: This study suggests that cannabinoid agonists, specifically the CB1R agonist WIN, may not be effective in treating cerebellar ataxia and may even worsen symptoms. However, co-administration of the CB1R antagonist AM251 with WIN can prevent some ataxic symptoms. This indicates that cannabinoid modulation of ataxia symptoms may involve other cannabinoid receptors in addition to CB1Rs.

EXPERIMENTAL BRAIN RESEARCH (2022)

Review Medicine, General & Internal

Mechanisms of COVID-19-induced cerebellitis

Mohammad Banazadeh, Sepehr Olangian-Tehrani, Melika Sharifi, Mohammadreza Malek-Ahmadi, Farhad Nikzad, Nooria Doozandeh-Nargesi, Alireza Mohammadi, Gary J. Stephens, Mohammad Shabani

Summary: The COVID-19 pandemic caused by SARS-CoV2 has raised significant health concerns, including increased mortality and morbidity. SARS-CoV2 can infect the central nervous system, particularly the cerebellum, leading to various sequelae such as thrombosis, hemorrhage, stroke, autoantibody production, ataxia, and widespread inflammation. These effects should be taken into consideration for disease prognosis.

CURRENT MEDICAL RESEARCH AND OPINION (2022)

Article Neurosciences

The cannabinoid antagonist, AM251 attenuates ataxia related deficiencies in a cerebellar ataxic model

Hoda Ranjbar, Monavareh Soti, Kristi A. Kohlmeier, Vahid Sheibani, Meysam Ahmadi-Zeidabadi, Kiana Rafiepour, Mohammad Shabani

Summary: The study suggests that treatment with AM251 can protect cerebellar PCs and improve motor function in a cerebellar ataxic model.

INTERNATIONAL JOURNAL OF NEUROSCIENCE (2022)

Article Behavioral Sciences

Antigen B modulates anti-inflammatory cytokines in the EAE model of multiple sclerosis

Aliakbar Mariki, Zahra Barzin, Majid Fasihi Harandi, Kimia Karbasi Ravari, Mahboubeh Davoodi, Seyed Mohammad Mousavi, Soheila Rezakhani, Masoud Nazeri, Mohammad Shabani

Summary: This study found that antigen B from hydatid cyst fluid could reduce the levels of anti-inflammatory cytokines in rats with experimental autoimmune encephalomyelitis (EAE)-induced multiple sclerosis (MS) and increase nerve conduction velocity. The results showed that antigen B modulated the immune system and reduced the inflammatory component of the EAE MS animal model, leading to a decrease in symptoms at the behavioral and electrophysiological level. Antigen B could be used as a potential therapeutic agent to regulate the immune system in MS patients.

BRAIN AND BEHAVIOR (2023)

Article Developmental Biology

Administration of agmatine prior to physical or psychological stress in pregnant mice ameliorates behavioural and cognitive deficits in female offspring

Amin Hassanshahi, Mahyar Janahmadi, Moazamehosadat Razavinasab, Mehran Ilaghi, Kristi A. Kohlmeier, Elham Hassanshahi, Mohammad Shabani

Summary: In this study, the researchers found that prenatal agmatine exposure could ameliorate behavioural and cognitive deficits in female offspring born to prenatally stressed mice. This study contributes to a better understanding of the effects of prenatal stress on newborns and provides a foundation for targeted prenatal treatments.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2023)

Article Developmental Biology

Chronic morphine exposure and maternal separation induce impairments in cognition and locomotor activity of male adolescent rats

Maysam Fadaei-kenarsary, Khadijeh Esmaeilpour, Mohammad Shabani, Sara Joushi, Vahid Sheibani

Summary: Maternal morphine exposure reduces motivation for cognitive tasks and leads to deficits in attention, accuracy, and executive function. It also induces depression-like behaviors and has negative consequences for learning and memory in offspring. Maternal separation can cause behavioral and neuropsychiatric abnormalities later in life. This study aimed to evaluate the effects of chronic morphine consumption and maternal separation on the cognitive and behavioral performance of male adolescent rats. The results showed that maternal separation increased locomotor activity and movement velocity, while morphine exposure worsened body stretching behavior. Maternal separation also resulted in spatial learning deficits, but recognition and spatial memory were not significantly affected. Overall, these findings suggest that maternal morphine exposure and maternal separation can impair cognitive and behavioral performance in adolescent male rats.

INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2023)

Article Behavioral Sciences

Impact of ketamine administration on chronic unpredictable stress-induced rat model of depression during extremely low-frequency electromagnetic field exposure: Behavioral, histological and molecular study

Moein Salari, Seyed Hassan Eftekhar-Vaghefi, Majid Asadi-Shekaari, Khadijeh Esmaeilpour, Somayeh Solhjou, Maryam Amiri, Meysam Ahmadi-Zeidabadi

Summary: In this study, we examined the effects of ketamine and extremely low-frequency electromagnetic fields (ELF-EMF) on depression-like behavior, learning and memory, and the expression of GFAP, caspase-3, p53, BDNF, and NMDA receptor in animals subjected to chronic unpredictable stress (CUS). The results revealed that the combination of ketamine and ELF-EMF had adverse effects on animals under chronic unpredictable stress.

BRAIN AND BEHAVIOR (2023)

Review Developmental Biology

Cannabis during pregnancy: A way to transfer an impairment to later life

Sina Motamedi, Reza Saboori Amleshi, Behnoush Akbari Javar, Parisa Shams, Kristi A. Kohlmeier, Mohammad Shabani

Summary: Epidemiological studies have shown that exposure to cannabis during gestation or the perinatal period can lead to mental health issues in childhood, adolescence, and adulthood. There is a high risk of negative outcomes in individuals with specific genetic variants, suggesting an interaction between cannabis usage and genetics. Animal research has also demonstrated long-term effects of prenatal and perinatal exposure to psychoactive components on neural systems relevant to psychiatric and substance use disorders. This article discusses the molecular, epigenetic, electrophysiological, and behavioral consequences of prenatal and perinatal exposure to cannabis.

BIRTH DEFECTS RESEARCH (2023)

Review Multidisciplinary Sciences

Cross-talk between the HPA axis and addiction-related regions in stressful situations

Marjan Nikbakhtzadeh, Hoda Ranjbar, Khadijeh Moradbeygi, Elham Zahedi, Mahnaz Bayat, Monavareh Soti, Mohammad Shabani

Summary: Addiction is a worldwide problem with significant costs on health care, public security, and the community economic cycle. Stress plays a crucial role in the development of addiction and relapse vulnerability. This review examines the impact of stress on the Hypothalamus-Pituitary-Adrenal (HPA) axis and internal factors, such as neuro-inflammatory, neurotrophic, and neurotransmitter factors, and their effects on drug addiction vulnerability, craving, and relapse susceptibility.

HELIYON (2023)

Article Dentistry, Oral Surgery & Medicine

A case of conversion disorder presenting as chronic trismus

Robert L. Merrill, Donald Goodman, Goli Chamani, Mohammad Shabani

Summary: Trismus can occur as a symptom of various diseases, with articular disorders being the most common cause. However, in rare cases, the cause may be extra-articular. This report describes a case of non-articular hysterical trismus in an 11-year-old boy, resulting in complete jaw lock and significant pain for 3 months. After three therapy sessions, the patient achieved significant improvement in mouth opening and resumed normal eating. This highlights the importance of comprehensive history taking and thorough clinical examination for accurate diagnosis of trismus, particularly in cases involving conversion disorders.

SPECIAL CARE IN DENTISTRY (2023)

Article Developmental Biology

Preventive putative effect of agmatine on cognitive and molecular outcomes in ventral tegmental area of male offspring following physical and psychological prenatal stress

Amin Hassanshahi, Mahyar Janahmadi, Moazamehosadat Razavinasab, Hoda Ranjbar, Narges Hosseinmardi, Gila Behzadi, Kristi A. Kohlmeier, Mehran Ilaghi, Mohammad Shabani

Summary: Prenatal stress (PS) can lead to behavioral disorders in offspring, such as substance abuse and anxiety. This study investigated the effects of agmatine on cognitive outcomes in male mice exposed to PS and molecular changes in the ventral tegmental area (VTA). The results showed that agmatine reduced locomotor activity impairment and conditioned place preference to morphine in PS offspring. Agmatine also improved anxiety-like behavior and drug-seeking behavior induced by PS. The molecular effects were observed in the VTA, with agmatine reducing enhanced brain-derived neurotrophic factor (BDNF) levels. Overall, prenatal treatment with agmatine protected against the negative consequences of PS on the development of affective circuits in offspring.

DEVELOPMENTAL PSYCHOBIOLOGY (2023)

Article Neurosciences

Exploring the potential of a novel phenoxyethyl piperidine derivative with cholinesterase inhibitory properties as a treatment for dementia: Insights from STZ animal model of dementia

Fatemeh Abolhasani, Yaghoub Pourshojaei, Fatemeh Mohammadi, Khadijeh Esmaeilpour, Ali Asadipour, Mehran Ilaghi, Mohammad Shabani

Summary: This study evaluated the effects of a synthetic phenoxyethyl piperidine derivative, compound 7c, as a novel dual inhibitor of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE), on learning and memory in an animal model of Alzheimer's disease (AD). The findings suggest that compound 7c acts as a central AChE inhibitor and has therapeutic potential in alleviating cognitive deficits in AD dementia.

NEUROSCIENCE LETTERS (2023)

No Data Available